SABRE: Adding risedronate to anastrozole improved BMD in postmenopausal women with early breast cancer | HemOncToday

Links shared publicly online about this topic.

  • 1,445
    total visits

SABRE: Adding risedronate to anastrozole improved BMD in postmenopausal women with early breast cancer | HemOncToday

hemonctoday.com

In postmenopausal women receiving the aromatase inhibitor anastrozole for the treatment of hormone receptor-positive early breast cancer, the

View full resource at hemonctoday.com

Tags: Hormone, Cancer, Breast Cancer, Breast Cancer Medication, Osteoporosis Medication, Women's Health, Actonel, Arimidex

  • Share

Most Recently Shared on January 19, 2010 at 3:07 pm By:

teamoncology Naoto T. Ueno

Will see what it means. RT @HemOncToday: Adding risedronate to anastrozole improved BMD, postmenopausal w/early breast ca http://ow.ly/YaS0

2 years ago...

Also Shared By:

HemOnc Today HemOnc Today

Advertisement